When it comes to landing the ideal job, having a great start can make all the difference. When it comes to working in cyberinfrastructure or research computing, there isn’t a much better way to start ...

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported business highlights and third quarter 2024 financial results. "This is ...

Positive Phase 1a interim data released for ABI-5366, a long-acting HSV helicase-primase inhibitor candidate for recurrent genital herpes, ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of HIV research findings at the International ...

a capsid assembly modulator for chronic Hepatitis B treatment. The upcoming AASLD 2024 conference is expected to showcase promising interim data from a Phase 1a/1b study, demonstrating high viral ...

Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported business highlights and third quarter 2024 financial ...

In an article published in Plos Biology, scientists show that the attachment of a retrovirus protein, called Gag, which plays a central role in the formation of viral particles, is necessary but ...

DALLAS, TX / ACCESSWIRE / November 6, 2024 / Adnexus Biotechnologies Inc. is pleased to announce the completion of a merger agreement with Sanctum Therapeutics Corporation to acquire Sanctum ...

This is the context which saw the development of e4shield tm,the innovative technology that uses electromagnetic waves to ...

Matica Biotechnology (Matica Bio), a leading contract development and manufacturing organization (CDMO) for viral vectors, ...